Alta Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Sell
12,355
-113
-0.9% -$14.9K 0.42% 54
2026
Q1
$1.74M Sell
12,468
-3
-0% -$420 0.56% 42
2025
Q4
$1.53M Buy
12,471
+106
+0.9% +$12.9K 0.51% 44
2025
Q3
$1.37M Sell
12,365
-74
-0.6% -$8.41K 0.49% 50
2025
Q2
$1.38M Buy
12,439
+1
+0% +$106 0.65% 36
2025
Q1
$1.39M Buy
12,438
+411
+3% +$42.4K 0.64% 34
2024
Q4
$1.11M Buy
12,027
+7
+0.1% +$630 0.49% 47
2024
Q3
$1.01M Sell
12,020
-19
-0.2% -$1.45K 0.46% 51
2024
Q2
$826K Buy
12,039
+27
+0.2% +$1.8K 0.41% 58
2024
Q1
$880K Buy
12,012
+337
+3% +$25.9K 0.45% 55
2023
Q4
$946K Sell
11,675
-53
-0.5% -$4.12K 0.53% 50
2023
Q3
$879K Sell
11,728
-148
-1% -$11.4K 0.54% 53
2023
Q2
$915K Buy
11,876
+299
+3% +$23.8K 0.54% 54
2023
Q1
$961K Buy
11,577
+101
+0.9% +$8.37K 0.61% 47
2022
Q4
$985K Buy
11,476
+493
+4% +$39K 0.67% 40
2022
Q3
$678K Buy
10,983
+850
+8% +$53.6K 0.49% 60
2022
Q2
$626K Hold
10,133
0.43% 65
2022
Q1
$602K Buy
+10,133
New +$648K 0.36% 87

Other funds holding GILD

Alta Wealth Advisors's GILD Position: Q2 2026 in Review

Alta Wealth Advisors reduced its Gilead Sciences (GILD) stake by 0.91% in Q2 2026, selling an estimated $14.9K and leaving 12,355 shares worth $1.56M. The position accounts for 0.42% of the portfolio, ranked #54.

Alta Wealth Advisors first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.74M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Alta Wealth Advisors held 12,355 shares of Gilead Sciences worth $1.56M as of Q2 2026.
  • Alta Wealth Advisors sold 113 Gilead Sciences shares in Q2 2026, an estimated $14.9K.
  • Gilead Sciences made up 0.42% of Alta Wealth Advisors's portfolio in Q2 2026, its #54 holding.
  • Alta Wealth Advisors first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
  • Alta Wealth Advisors's Gilead Sciences position peaked at $1.74M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Alta Wealth Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.